Health ❯ Clinical Trials

Gene Therapy

Wet Age-Related Macular Degeneration (AMD) Heart Failure Treatment FDA Approval Heart Disease Sickle Cell Disease CRISPR Cell Therapy Patient Treatment Patient Outcomes FDA Regulations ANGPTL3 Gene

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit

Plaintiffs tie losses to FDA trial holds disclosed Jan. 28 after a reported tumor in a participant.